Salzmann Gian M, Erdle Benjamin, Porichis Stella, Uhl Markus, Ghanem Nadir, Schmal Hagen, Kubosch David, Südkamp Norbert P, Niemeyer Philipp
Department of Orthopaedic and Trauma Surgery, University Medical Center, Albert-Ludwigs University Freiburg, Freiburg, Germany
Department of Orthopaedic and Trauma Surgery, University Medical Center, Albert-Ludwigs University Freiburg, Freiburg, Germany.
Am J Sports Med. 2014 Aug;42(8):1832-40. doi: 10.1177/0363546514536682. Epub 2014 Jun 16.
There are several reports on long-term clinical outcomes after autologous chondrocyte implantation (ACI) for knee cartilage defect treatment. Few published articles have evaluated defect quality using quantitative magnetic resonance (MR) imaging techniques.
To evaluate clinical outcomes and the quality of repair tissue (RT) after first-generation periosteum-covered ACI (ACI-P) using qualitative MR outcomes and T2-weighted relaxation times.
Case series; Level of evidence, 4.
All patients (n = 86) who underwent knee joint ACI-P (from 1997 through 2001) with a postoperative follow-up of at least 10 years were invited for clinical and MR evaluation. Clinical outcomes analysis included pre- and postoperative Lysholm and numeric analog scale (NAS) for pain (10 = worst, 0 = best). Radiographic analysis included postoperative T2-weighted mapping of the RT, RT-associated regions, and healthy control cartilage; MOCART (magnetic resonance observation of cartilage repair tissue) score; a modified Knee Osteoarthritis Scoring System (mKOSS; 0 = best, 15 = worst) score; as well as numeric grading for subjective RT and whole knee joint evaluation (1 = best, 6 = worst).
A total of 70 patients (45 male, 25 female; mean age, 33.3 ± 10.2 years; 81% follow-up rate) with 82 defects were available for follow-up at an average 10.9 ± 1.1 years postoperatively, with MR analysis for 59 patients with 71 transplant sites (average defect size, 6.5 ± 4.0 cm(2)). Final Lysholm (71.0 ± 17.4) and NAS (7.2 ± 1.9) scores improved significantly when compared with preoperative scores (Lysholm: 42.0 ± 22.5; NAS: 2.1 ± 2.1; P < .01 for both). Average transplant T2 was 35.2 ± 11.3 ms and thereby significantly lower (P = .005) when compared to the intraknee healthy femur T2 (39.7 ± 6.8 ms). The MOCART was 44.9 ± 23.6 and mKOSS was 4.8 ± 3.2. RT subjective grading was 3.3 ± 1.4, while it was 2.3 ± 0.7 for whole joint evaluation. The RT T2 significantly correlated with postoperative NAS (P = .04; r = -0.28); it also correlated with the healthy femur T2 (P = .004; r = 0.4). The MOCART significantly correlated with the mKOSS (P < .001).
The MRI outcome is imperfect in this collective of patients. There is only weak correlation of quantitative imaging data and clinical function. Qualitative imaging data are much better correlated to functional outcomes.
关于自体软骨细胞移植(ACI)治疗膝关节软骨缺损后的长期临床结果已有多篇报道。很少有已发表的文章使用定量磁共振(MR)成像技术评估缺损质量。
使用定性MR结果和T2加权弛豫时间评估第一代骨膜覆盖的ACI(ACI-P)术后的临床结果和修复组织(RT)质量。
病例系列;证据等级,4级。
邀请所有在1997年至2001年期间接受膝关节ACI-P且术后随访至少10年的患者(n = 86)进行临床和MR评估。临床结果分析包括术前和术后的Lysholm评分以及疼痛数字模拟量表(NAS)(10分表示最差,0分表示最佳)。影像学分析包括术后RT、RT相关区域和健康对照软骨的T2加权成像;MOCART(软骨修复组织磁共振观察)评分;改良的膝关节骨关节炎评分系统(mKOSS;0分表示最佳,15分表示最差)评分;以及RT主观评分和全膝关节评估的数字分级(1分表示最佳,6分表示最差)。
共有70例患者(45例男性,25例女性;平均年龄33.3±10.2岁;随访率81%),82处缺损,术后平均随访10.9±1.1年,59例患者的71个移植部位进行了MR分析(平均缺损大小6.5±4.0 cm²)。与术前评分相比,最终的Lysholm评分(71.0±17.4)和NAS评分(7.2±1.9)显著改善(Lysholm:42.0±22.5;NAS:2.1±2.1;两者P均<.01)。移植组织的平均T2为35.2±11.3 ms,与膝关节内健康股骨的T2(39.7±6.8 ms)相比显著更低(P =.005)。MOCART评分为44.9±23.6,mKOSS评分为4.8±3.2。RT主观评分为3.3±1.4,全关节评估为2.3±0.7。RT的T值与术后NAS显著相关(P =.04;r = -0.28);也与健康股骨的T值相关(P =.004;r = 0.4)。MOCART与mKOSS显著相关(P <.001)。
在该患者群体中,MRI结果并不理想。定量成像数据与临床功能之间仅有微弱相关性。定性成像数据与功能结果的相关性更好。